Netherlands

Netherlands country outline

Estimated Number of Current PrEP Users

200-400

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

200-400

Types of Delivery Projects

  • Demonstration project

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are approved for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned research/demonstration projects in Netherlands.

Policy Framework

HIV Pre-exposure Prophylaxis (PrEP) Guideline for the Netherlands (2017)

Funding

Academic Medical Center, PHSA


Eligibility Criteria
Resources for Netherlands
Glossary of Terms

Last updated April 16, 2018.

News Spotlight